Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03327948 · ClinicalTrials.gov registry record · NA
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt
A NA study, sponsored by Axonics.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
NCT03327948 is a NA study that has completed, run by Axonics. The registered enrollment target is 129 participants.
The verdict
NCT03327948, a NA study, has completed, sponsored by Axonics.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
Study Summary
The ARTISAN-SNM study is designed to evaluate the safety and effectiveness of the Axonics Sacral Neuromodulation System as an aid in the treatment of the symptoms of urinary urgency incontinence (UUI) in patients who have failed or could not tolerate more conservative treatments.
Interventions
- DEVICE Axonics Sacral Neuromodulation System (SNM) System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2017-11-21 |
| Est. Completion | 2020-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03327948
The ClinicalTrials.gov registry entry for NCT03327948 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Axonics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Axonics Sacral Neuromodulation System (SNM) System is the first listed.
NCT03327948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03327948 about?
NCT03327948 is a clinical study titled "Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt". The ARTISAN-SNM study is designed to evaluate the safety and effectiveness of the Axonics Sacral Neuromodulation System as an aid in the treatment of the symptoms of urinary urgency incontinence (UUI) in patients who have failed or could not tolerate more conservative treatments.
What is the current status of trial NCT03327948?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2017-11-21. Estimated completion is 2020-06-29.
What interventions are being tested in trial NCT03327948?
The interventions under investigation include: Axonics Sacral Neuromodulation System (SNM) System (DEVICE).
Who is sponsoring clinical trial NCT03327948?
This trial is sponsored by Axonics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.